https://pipelinereview.com/Noxxon-Pharma-signs-clinical-immuno-oncology-collaboration-agreement-with-MSD-to-study-NOX-a12-combined-with-Keytruda-pembrolizumab-in-pancreatic-and-colorectal-cancer/